Table 1 Clinical characteristics of the PTC validation cohort

Total number

50

N/A

Sex

 Male

10

20

 Female

40

80

Age at diagnosis

 Mean ± SD

36 ± 10.1

N/A

 Range

15–53

Tumor size (cm)

 Mean ± SD

2.532 ± 1.337

N/A

 Range

0.3–6

Tumor stage

 pT1a/b

28

56

 pT2

15

30

 pT3

7

14

Mutations

 BRAF V600E

34

64

 TERT promoter

1

2

Metastasis

 Lymph node

32

64

 Distant

3

6

Outcome at follow-up

 Alive, no recurrence

39

78

 Alive, recurrent disease

6

12

 Dead of disease

3

6

 Dead of other causes

2

4